Description: The first of two parts of a panel discussion, by conference call, on the the evolution of Enterprise Risk Management at life insurance companies, and actuaries' roles in that evolution.

Description: Scenario generators used in financial models to quantify risk are sometimes described as being as either “real-world” or “risk-neutral”. The difference is in the treatment of the market price of risk. This report explores the relationship between real-world and risk-neutral scenarios and when it is appropriate to use each type.

Description: Chairperson's summary of Joint Risk Management Section (JRMS) Council accomplishments during the 2021-2022 Section Council year, as part of the December 2022 Risk Management newsletter. Includes an introduction to new council members, appreciation to those departing the Council, and introduces the new JRMS Council Leadership. Discusses the accomplishments made, areas of focus and activities underway which benefit JRMS Section members.

Description: This article describes the similarities and differences between two forms of risk transfer, then concludes with a discussion of the implications of this difference for enterprise risk management

Description: COVID19 highlights the need for greater complexity expertise in risk management. Crisis like the current COVID19 pandemic and 2008 Financial meltdown and others help us to turn into focus inwards for introspection on how we can better manage our resources and provide a deeper understanding of what our objectives should be and how we can achieve them through applying complexity science.

Description: Feature article discussing the PBGC’s asset reallocation plan.

Description: How insurers can include a liquidity score and liquidity stress scenarios as part of their asset liability management (ALM) protocol.

Description: Reunite with members and non-members in the China actuarial community to discuss recent topics and related issues in areas such as macroeconomic sharing, IFRS 17, product strategy, cross-border communication and discussion, and more. Advance your career through learning and networking opportunities, and share your experiences in the finance and insurance industries, as well as other fields related to actuarial science.

Description: The working life of actuaries has become faster paced, more complex, and potentially more volatile than in any previous period in the history of the profession. Furthermore, actuaries are increasingly being asked to expand their roles into areas that lie beyond the traditional space associated with the actuarial profession. As a result, actuaries are increasingly finding themselves faced with professional and ethical dilemmas for which there is little precedent to rely for guidance. Take part in a guided discussion about three real-world case studies where actuaries were required to make difficult decisions. We will see how by remaining calm and leaning on the ASOPs, actuaries were able to navigate professional and ethical pitfalls despite pressure from key stakeholders. Each case study will highlight actuaries working in different areas within the industry. Some examples may include: - Case study 1: An actuary working for a direct insurer finds a last-minute error during a busy production cycle. - Case study 2: An actuary working for a reinsurer finds themselves under pressure to apply an unrealistic assumption. - Case study 3: An actuarial consultant is under pressure from a non-actuarial client to perform work in a way that would not comply with actuarial standards. By attending the session, you will: - Understand how to lean on the ASOPs to keep cool during stressful situations. - Manage deadlines and expectations. - Balance risk and reward, and remain true professionals, no matter how hot the fire.

Description: The most recent U.S. population data released by the Centers for Disease Control and Prevention (CDC) and from the U.S. Census at year-end 2021 includes the first ten months of the COVID-19 pandemic in the U.S. While we know the pandemic has had significant impacts on both the U.S. population and insured population mortality, we also see increased mortality due to many other non-COVID causes of death. Where are the biggest changes and what does this non-COVID excess mortality mean over the next few years? Take part as an expert panel hosts an interactive discussion to examine data from general population as well as from both individual life and group life experience studies to explore how these changes might spur innovation in underwriting, assumption setting and pricing.